Intuitive Surgical Secures U.S. Market Leadership with da Vinci 5 Adoption
Intuitive Surgical (ISRG) has solidified its dominance in the U.S. robotic surgery market with the rapid adoption of its da Vinci 5 system, securing hospital capital budgets ahead of competitors like Medtronic (MDT) and Johnson & Johnson (JNJ). The company reported strong financial performance, including a 23% revenue growth and 86% recurring revenue, driven by digital services and AI training. This positions ISRG for long-term market leadership.
Topics: da Vinci 5 Intuitive Surgical market share Q1 2026 performance recurring revenue robotic surgery